Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Drug maker Pfizer has filed a lawsuit against India-based drug manufacturer Aurobindo Pharma over generic Lipitor which is indicated as a treatment for cholesterol and for lowering stroke, heart attack or other heart complications in patients type 2 diabetes.
Subscribe to our email newsletter
Pfizer has sued Aurobindo Pharma in connection with its filing of abbreviated new drug application (ANDA) for marketing generic version of Lipitor, Atorvastatin in the US market.
The lawsuit was filed to stop the Indian firm to manufacture and market the drug prior the expiration of its patent date i.e 8 January 2017.
The suit was filed in the US District Court of Delaware on 17 May.